SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies in anticipation of a large token burn at 3000 watchers, which they believe will trigger a bullish shift. Community members highlight the project's commitment to organic growth, transparency, and consistent development within the Solana ecosystem. They are drawing comparisons to Gamestop's historical pump, with the goal of achieving financial freedom.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending as chatter revolves around anticipation for a HBAR ETF potentially launching soon, generating excitement for institutional investment. Community members are actively discussing potential price targets and loading up on tokens, while highlighting Hedera's strong technology and real-world use cases. Some investors view HBAR as a promising altcoin with long-term growth potential amid broader discussions of market regulation and infrastructure.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending due to a mix of analyst ratings and community sentiment regarding future performance; Northland Securities raised its price target, while others maintain lower targets. Discussions revolve around the impact of deferred revenue and potential earnings beats, with many investors weighing the impact of Jim Cramer's negative sentiment. Overall, the community is focused on Super Micro Computer's potential in the AI infrastructure market amid concerns about management's execution.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Shares of Intellia Therapeutics are trending due to a significant drop following a pause in late-stage trials for their leading therapy, nex-z, after a patient experienced liver problems; however, some investors view this as an overreaction and a buying opportunity, especially given Cathie Wood's recent purchase of a large number of shares. The community is actively debating whether the decline is justified and discussing potential recovery catalysts. Some traders are also noting a high short interest and anticipating a potential short squeeze.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending as investors discuss its integral role in the AI and semiconductor sectors, particularly with potential benefits arising from recent partnerships and increased demand for advanced chip manufacturing equipment. Community discussions revolve around its monopolistic position and future growth prospects, balanced with concerns about valuation and geopolitical factors affecting the sector. Additionally, analysts are weighing in with upgrades and target adjustments, influencing market sentiment.

USDC is a fully collateralized US dollar stablecoin. USDC is the bridge between dollars and trading on cryptocurrency exchanges. The technology behind CENTRE makes it possible to exchange value between people, businesses and financial institutions just like email between mail services and texts between SMS providers. We believe by removing artificial economic borders, we can create a more inclusive global economy.

USD Coin

USD Coin is trending as communities discuss its potential use in tokenizing real-world assets and broader implications for stablecoin adoption. Discussions include its role in on-chain markets, regulatory developments, and comparisons to other stablecoins. The community is also actively following partnerships and staking opportunities involving USDC.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

LUMN is trending due to growing excitement around its potential role in the AI race and a recent partnership, sparking discussions of a short squeeze and significant upside. Community members are actively debating its future earnings potential, with some eyeing specific price targets and others seeing it as a long-term play. Bullish sentiment is fueled by BlackRock's ownership and the perception that LUMN is undervalued given its essential infrastructure.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Cybin Inc

Cybin is trending amid discussions about a recent financing agreement and its potential impact on the stock's value, with some community members expressing concern over possible dilution. Despite this, optimism persists around Cybin's clinical trials, particularly its Phase 3 program, and its position within the psychedelic therapeutics sector. The community is weighing the company's prospects against those of its competitors like CMPS and ATAI.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy ($FLNC) is trending as chatter suggests a potential short squeeze, with investors highlighting its high short interest and low days to cover. Community members are discussing analyst upgrades and the company's position in the growing energy storage sector. Some traders are speculating on potential buyout news or a BlackRock deal, while others remain cautious about valuation and upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

atai Life Sciences (ATAI) Upgraded to Buy: Here's Why

atai Life Sciences (ATAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Are Medical Stocks Lagging  atai Life Sciences (ATAI) This Year?

Here is how atai Life Sciences N.V. (ATAI) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.

atai Life Sciences (ATAI) Upgraded to Buy: Here's What You Should Know

atai Life Sciences (ATAI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Are Medical Stocks Lagging  Halozyme Therapeutics (HALO) This Year?

Here is how Halozyme Therapeutics (HALO) and atai Life Sciences N.V. (ATAI) have performed compared to their sector so far this year.

Here's Why atai Life Sciences (ATAI) Is a Great 'Buy the Bottom' Stock Now

atai Life Sciences (ATAI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

atai Life Sciences (ATAI) Upgraded to Strong Buy: Here's Why

atai Life Sciences (ATAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year?

Here is how atai Life Sciences N.V. (ATAI) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.

5 Biotech Stocks with Highly Anticipated Pending Results

Others

Biotech M&A is heating up, making small-cap firms with breakthrough assets top acquisition targets and potential big winners for investors.

Are You Looking for a Top Momentum Pick? Why atai Life Sciences N.V. (ATAI) is a Great Choice

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.

ATAI Life Sciences N.V.

Will Alphabet ($GOOGL) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Alphabet Inc Class A

) beat quarterly earnings? 
 
*Powered by Polymarket

ATAI
ATAI Life Sciences N.V.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ATAI News

ATAIATAI Life Sciences N.V.